Fractyl Health, Inc.: research and development expense
Research and development expense for Fractyl Health, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Fractyl Health, Inc. financial histories
What this measure means
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
Exact concept: us-gaap:ResearchAndDevelopmentExpense. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2023-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 74,536,000 | USD | 2026-03-24 | 10-K · 0001193125-26-121793 |
| 2024-01-01 | 2024-12-31 | 70,471,000 | USD | 2026-03-24 | 10-K · 0001193125-26-121793 |
| 2023-01-01 | 2023-12-31 | 38,038,000 | USD | 2025-03-03 | 10-K · 0000950170-25-030807 |
Related financial histories
- Fractyl Health, Inc.: total assets
- Fractyl Health, Inc.: total liabilities
- Fractyl Health, Inc.: stockholders equity
- Fractyl Health, Inc.: cash and cash equivalents
- Fractyl Health, Inc.: net income or loss
- Fractyl Health, Inc.: operating cash flow
- Fractyl Health, Inc.: capital expenditure payments
- Fractyl Health, Inc.: financing cash flow
- Fractyl Health, Inc.: investing cash flow
- Fractyl Health, Inc.: retained earnings or deficit
- Fractyl Health, Inc.: basic weighted-average shares
- Fractyl Health, Inc.: diluted weighted-average shares
- Fractyl Health, Inc.: basic earnings per share
- Fractyl Health, Inc.: diluted earnings per share
- Fractyl Health, Inc.: net property, plant and equipment
- Fractyl Health, Inc.: share-based compensation expense
- Fractyl Health, Inc.: operating income or loss
- Fractyl Health, Inc.: current assets
- Fractyl Health, Inc.: current liabilities
- Fractyl Health, Inc.: current accounts payable
- Fractyl Health, Inc.: operating expenses
- Fractyl Health, Inc.: cost of revenue
- Fractyl Health, Inc.: selling, general and administrative expense
- Fractyl Health, Inc.: common shares outstanding
- Fractyl Health, Inc.: cash including restricted cash
- Fractyl Health, Inc.: additional paid-in capital
- Fractyl Health, Inc.: operating lease right-of-use asset
- Fractyl Health, Inc.: gross property, plant and equipment
- Fractyl Health, Inc.: accumulated depreciation on property, plant and equipment
- Fractyl Health, Inc.: other noncurrent assets
- Fractyl Health, Inc.: profit or loss including noncontrolling interests
- Fractyl Health, Inc.: net income available to common stockholders
- Fractyl Health, Inc.: depreciation expense
- Fractyl Health, Inc.: other nonoperating income or expense
- Fractyl Health, Inc.: nonoperating income or expense
- Fractyl Health, Inc.: interest paid, net
- Fractyl Health, Inc.: change in accounts payable
Inspect the source
- Entity
- Fractyl Health, Inc. / CIK 0001572616
- Captured
- 2026-09-20T09:21:31.101Z
- SEC response SHA-256
e6723a5db477c9672ff1e22242541e6ff45aedd82bbf87feacd0652b7dded0a9
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001572616.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))